Señales en vivo de JXFGF | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (11 abr 2024 @ 09:34):

Stats
Volumen de hoy	1 323.00
Volumen promedio	353.00
Capitalización de mercado	538.77M
EPS	$0 ( 2023-03-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	10.00
ATR14	$0.00100 (0.50%)

Volumen Correlación

Largo: -0.38 (neutral)

Corto: -0.59 (weak negative)

Signal:(0.055) Neutral

Jinxin Fertility Group Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Jinxin Fertility Group Correlación - Moneda/Commodity

-0.12
( neutral )

-0.51
( weak negative )

0.00
( neutral )

-0.75
( moderate negative )

0.00
( neutral )

0.71
( moderate )

Jinxin Fertility Group Finanzas

Annual	2023
Ingresos:	$2.79B
Beneficio Bruto:	$1.18B (42.15 %)
EPS:	$0.130

FY	2023
Ingresos:	$2.79B
Beneficio Bruto:	$1.18B (42.15 %)
EPS:	$0.130

FY	2022
Ingresos:	$2.36B
Beneficio Bruto:	$874.32M (36.98 %)
EPS:	$0.0485

Financial Reports:

No articles found.

Jinxin Fertility Group Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Jinxin Fertility Group

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.